section name header

Pronunciation

pin-ah-VEER-ee-um

Classifications

Therapeutic Classification: anti irritable bowel syndrome agents

Pharmacologic Classification: calcium channel blockers

Indications

REMS


Action

  • Acts as a calcium channel blocker with specific selectivity for intestinal smooth muscle.
  • Relaxes gastrointestinal (mainly colon) and biliary tracts, inhibits colonic motor response to food/pharmacologic stimulation.
Therapeutic effects:
  • Decreased symptoms of IBS.

Pharmacokinetics

Absorption: Poorly absorbed (1–10%).

Distribution: Distributes selectively to digestive tract.

Protein Binding: 97%.

Metabolism/Excretion: Minimal enterohepatic cycling, eliminated almost entirely in feces. Some metabolism.

Half-Life: 1.5 hr.

Time/Action Profile

(blood levels)

ROUTEONSETPEAKDURATION
POunknown1 hrunknown



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

All less than 1%

CNS: drowsiness, headache, vertigo

GI: constipation, diarrhea, distention, dry mouth, epigastric pain/fullness, esophageal irritation, nausea

Derm: rash

Interactions

Drug-drug:

Route/Dosage

Availability

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

Canadian Brand Names

Dicetel